| ERIS Lifesciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540596 |
NSE Symbol : ERIS |
P/E(TTM) : 60.22 |
|
ISIN Demat : INE406M01024 |
Div & Yield% : 0.56 |
EPS(TTM) : 21.44 |
|
Book Value(₹) : 230.54 |
Market Cap(₹Cr) : 17,887.27 |
Face Value(₹) : 1.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 306.78 | 637.58 | 567.90 | 395.71 | 390.00 | 428.75 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 306.78 | 637.58 | 567.90 | 395.71 | 390.00 | 428.75 |
| Other Operating Income | 8.51 | 12.92 | 10.74 | 9.06 | 9.73 | 7.81 |
| Other Income | 25.07 | 23.59 | 22.68 | 16.75 | 7.79 | 5.81 |
| Total Income | 340.36 | 674.09 | 601.32 | 421.52 | 407.52 | 442.37 |
| Total Expenditure | 252.61 | 353.62 | 362.32 | 283.80 | 300.16 | 293.93 |
| PBIDT | 87.75 | 320.47 | 239.00 | 137.72 | 107.36 | 148.44 |
| Interest | 45.20 | 46.50 | 45.14 | 53.16 | 54.65 | 56.26 |
| PBDT | 42.55 | 273.97 | 193.86 | 84.56 | 52.71 | 92.18 |
| Depreciation | 38.66 | 39.30 | 37.60 | 43.38 | 46.68 | 46.16 |
| Tax | 0.51 | 40.91 | 27.17 | 8.51 | 0.00 | 8.78 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.29 | 44.19 | 29.10 | 2.20 | 4.25 | 9.14 |
| Reported Profit After Tax | 3.09 | 149.57 | 99.99 | 30.47 | 1.78 | 28.10 |
| Extra-ordinary Items | -13.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 16.96 | 149.57 | 99.99 | 30.47 | 1.78 | 28.10 |
| EPS (Unit Curr.) | 0.23 | 10.98 | 7.34 | 2.24 | 0.13 | 2.06 |
| EPS (Adj) (Unit Curr.) | 0.23 | 10.98 | 7.34 | 2.24 | 0.13 | 2.06 |
| Calculated EPS (Unit Curr.) | 0.23 | 10.98 | 7.34 | 2.24 | 0.13 | 2.06 |
| Calculated EPS (Adj) (Unit Curr.) | 0.23 | 10.98 | 7.34 | 2.24 | 0.13 | 2.06 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.91 | 43.93 | 29.37 | 8.95 | 0.52 | 8.26 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.91 | 43.93 | 29.37 | 8.95 | 0.52 | 8.26 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 735.00 | 0.00 |
| Equity | 13.62 | 13.62 | 13.62 | 13.62 | 13.61 | 13.61 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 28.60 | 50.26 | 42.08 | 34.80 | 27.53 | 34.62 |
| PBDTM(%) | 13.87 | 42.97 | 34.14 | 21.37 | 13.52 | 21.50 |
| PATM(%) | 1.01 | 23.46 | 17.61 | 7.70 | 0.46 | 6.55 |
